#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oropharyngeal squamous cell carcinoma Pyruvate dehydrogenase complex deficiency Nephrotic syndrome Hereditary angioedema with C1 esterase inhibitor deficiency Intracranial germ cell tumour Chronic myeloid leukaemia (in remission) Non-small cell lung cancer recurrent Congenital hypotransferrinaemia Acute graft versus host disease in intestine Malignant fibrous histiocytoma Staphylococcal infection Ureteric cancer Pleomorphic leiomyosarcoma Breast cancer Epilepsy with myoclonic-atonic seizures More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Life with Disease Marginal zone lymphoma – Basic Information Testicular leiomyosarcoma Cholangitis sclerosing – Life with Disease Retinoblastoma – Trials in Disease Haemophilia A without inhibitors – Trials in Disease Soft tissue sarcoma – Diagnostics Von Willebrand’s disease – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Haemolytic uraemic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pbf-999 Elamipretide Trihydrochloride Bempikibart Propafenone Hydrochloride Bi-1910 GSKVX000000034795 E.coli Polysaccharide Gemcitabine Triptorelin Acetate Exagamglogene Autotemcel Tramadol PAPAVERINE HYDROCHLORIDE Dornase Alfa Carmustine Betibeglogene Autotemcel Corylus Avellana L. At-1501 Isoflurane Tozorakimab Pentetic Acid More therapies…

    Learn about Your Condition

    Hypersomnia Herpes zoster Appendicitis perforated Testicular germ cell cancer Meningioma malignant Cancer pain Epileptic encephalopathy Low cardiac output syndrome Tonsillitis Oesophageal food impaction Anal cancer Peritoneal sarcoma Hypoglycaemia Staphylococcal infection Congenital pseudarthrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Apremilast
    • Zasocitinib
    Bulgaria Czechia France Germany Greece Hungary +3

  • Study of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria

    Not recruiting

    2 1
    Investigated Diseases:
    • Urticaria chronic
    Denmark Germany Italy Spain

  • Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Sonelokimab
    Belgium Bulgaria Czechia France Germany Hungary +7

  • Study of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    • Ruxolitinib
    Belgium France Germany Hungary Italy Poland +1

  • Study of ruxolitinib cream for treating hidradenitis suppurativa in adult patients

    Not recruiting

    3 1
    Investigated Drugs:
    • Ruxolitinib
    Bulgaria France Germany Italy Poland Spain

  • Study of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Ruxolitinib
    Belgium Bulgaria France Germany The Netherlands Poland +1
Previous Page
1 … 33 34 35 36 37 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!